John Rotrosen

University School — United States

Medicine · Health Sciences

60h-index15.0kcitations358works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Substance Abuse Treatment and Outcomes(96), Opioid Use Disorder Treatment(96), Schizophrenia research and treatment(62), Neurotransmitter Receptor Influence on Behavior(43), Prenatal Substance Exposure Effects(24)

Publications358 total

A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Journal of Substance Use and Addiction Treatment·2025Open Access
Comparative effectiveness of extended‐release naltrexone versus buprenorphine‐naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population‐based observational data
Addiction·2025Open Access
A Comparison of Neuropsychological Functioning between Patients With Opioid Use Disorders on Extended-Release Naltrexone and Buprenorphine
Drug and Alcohol Dependence·2025
An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal
Drug and Alcohol Dependence·2025
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)
Contemporary Clinical Trials·2025· 2 citedOpen Access
Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial
Drug and Alcohol Dependence·2025Open Access
In Memoriam: Burton M. Angrist, MD
Neuropsychopharmacology·2024Open Access
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder
Drug and Alcohol Dependence·2024
Patient Characteristics Associated With Retention on XR-NTX in the CTN-0051 Trial
Drug and Alcohol Dependence·2024
Substance Use Screening Rates and Screening Results Among Adult Primary Care Patients With Mental Health Conditions and Substance Use-Related Medical Conditions
Drug and Alcohol Dependence·2024
An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal
Drug and Alcohol Dependence·2024
Impact of Medication-Based Treatment on Healthcare Utilization Among Individuals With Opioid Use Disorder: A Secondary Analysis of the X:BOT Clinical Trial
Drug and Alcohol Dependence·2024
Machine Learning–Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention
Journal of Addiction Medicine·2024· 4 citedOpen Access
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
JAMA Network Open·2024· 10 citedOpen Access
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial
Contemporary Clinical Trials·2024· 1 citedOpen Access
Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder
Addiction·2024· 9 citedOpen Access
Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial
Trials·2024· 5 citedOpen Access
Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone on Treatment Interruption: Comparing Findings from a Reanalysis of the X:Bot Rct and Harmonized Target Trial Emulation Using Population-Based Observational Data
SSRN Electronic Journal·2024Open Access
Optimizing Retention Strategies for Opioid Use Disorder Pharmacotherapy: The Retention Phase of the Ctn-0100 Trial (RDD)
SSRN Electronic Journal·2024Open Access
Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study
The Lancet Regional Health - Americas·2023· 15 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Adam Wolkin(9), Lenard A. Adler(8), Burt Angrist(7), Jennifer McNeely(6), Eric D. Peselow(6), Marc N. Gourevitch(5), Jonathan D. Brodie(5), June Corwin(5), Joshua D. Lee(4), Michael Sanfilipo(4), Erica Duncan(4), Stephen Gonzenbach(4), Sándor Miklós Szilágyi(4), Burton Angrist(4), Shiela M. Strauss(4), F. Xavier Castellanos(3), Clare Kelly(3), Michael P. Milham(3), Edward V. Nunes(3), Stephen Ross(3)